Structure-activity relationship of C4-substituted pyrimidopyrimidines; Dual KDR/FGFR tyrosine kinase inhibitors.

被引：0
|
作者：
Rossman, P
Luk, K
Chen, Y
Garafalo, L
Graves, B
Jackson, N
Kabat, M
Konzelmann, F
Liu, JJ
Lukacs, C
McDermott, L
Michoud, C
Portland, L
Roberts, J
Schutt, A
Simcox, M
So, SS
Tamborini, B
Yang, H
机构：
[1] Hoffmann La Roche Inc, Discovery Chem, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Chem Synth, Nutley, NJ 07110 USA
[3] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124-MEDI
引用
收藏
页码：U129 / U129
页数：1
相关论文
共 50 条
  • [11] Structure-activity relationship studies of sphingosine kinase inhibitors
    Raje, Mithun R.
    Kharel, Yugesh
    Lynch, Kevin R.
    Santos, Webster L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [12] Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors
    Tahtouh, Tania
    Durieu, Emilie
    Villiers, Benoit
    Bruyere, Celine
    Thu Lan Nguyen
    Fant, Xavier
    Ahn, Kwang H.
    Khurana, Leepakshi
    Deau, Emmanuel
    Lindberg, Mattias F.
    Severe, Elodie
    Miege, Frederic
    Roche, Didier
    Limanton, Emmanuelle
    L'helgoual'ch, Jean-Martial
    Burgy, Guillaume
    Guiheneuf, Solene
    Herault, Yann
    Kendall, Debra A.
    Carreaux, Francois
    Bazureau, Jean-Pierre
    Meijer, Laurent
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1396 - 1417
  • [13] Inhibitors of Src tyrosine kinase: The preparation and structure-activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolines
    Wang, YD
    Miller, K
    Boschelli, DH
    Ye, F
    Wu, BQ
    Floyd, MB
    Powell, DW
    Wissner, A
    Weber, JM
    Boschelli, F
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (21) : 2477 - 2480
  • [14] Structure-activity relationship and in silico development of c-Met kinase inhibitors
    Ghosh, Suparna
    Cho, Seung Joo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2022, 43 (06) : 882 - 892
  • [15] Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
    Hennequin, LF
    Thomas, AP
    Johnstone, C
    Stokes, ESE
    Plé, PA
    Lohmann, JJM
    Ogilvie, DJ
    Dukes, M
    Wedge, SR
    Curwen, JO
    Kendrew, J
    Lambert-van der Brempt, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5369 - 5389
  • [16] Structure-activity relationship study of (-)-epicatechin analogues as DNA methyltransferase inhibitors.
    Shaw, YJ
    Chen, CS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U186 - U187
  • [17] Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors
    Song, Jiho
    Lee, Jung Wook
    Chung, Shin Hyuck
    Wenas, Michelle A.
    Min, Kyung Hoon
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2017, 38 (11): : 1255 - 1256
  • [18] Quantitative structure-activity relationships (QSAR):: studies of inhibitors of tyrosine kinase
    Shen, Q
    Lü, QZ
    Jiang, JH
    Shen, GL
    Yu, RQ
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (01) : 63 - 71
  • [19] Inhibitors of the epidermal growth factor receptor protein tyrosine kinase: A quantitative structure-activity relationship analysis
    Singh, P
    Kumar, R
    JOURNAL OF ENZYME INHIBITION, 1998, 13 (02): : 125 - 134
  • [20] Synthesis and structure-activity relationship of inhibitors of protein kinase D
    Rosenker, Kara M. George
    Bravo-Altamirano, Karla
    Frantz, Marie-Celine
    LaValle, Courtney R.
    Tandon, Manuj
    Wang, Q. Jane
    Wipf, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
12345